Slug regulates Cyclin Dl expressionin by ubiquitin-proteasome pathway in prostate cancer cells

Panminerva Medica

Volumn 54, Issue 3, 2012, Pages 219-223

  Ding, G X ^a   Liu, J ^a   Feng, C C ^a   Jiang, H W ^a   Xu, J F ^a,b   Ding, Q ^a  

^a FUDAN UNIVERSITY   (China)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Cyclin Dl; Prostatic neoplasms; Ubiquitin

Indexed keywords

BENZYLOXYCARBONYLLEUCYL LEUCYL LEUCINE ALDEHYDE; BENZYLOXYCARBONYLLEUCYL-LEUCYL-LEUCINE ALDEHYDE; CYCLIN D1; LEUPEPTIN; MESSENGER RNA; PROTEINASE; SNAIL FAMILY TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR; UBIQUITIN; UBIQUITIN SPECIFIC PROTEASE; UBIQUITIN-SPECIFIC PROTEASE;

ARTICLE; BIOSYNTHESIS; CELL CYCLE; CELL PROLIFERATION; CHEMISTRY; DOSE RESPONSE; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; METABOLISM; MUTATION; PROSTATE TUMOR; TUMOR CELL LINE;

CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN D1; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; ENDOPEPTIDASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEUPEPTINS; MALE; MUTATION; PROSTATIC NEOPLASMS; RNA, MESSENGER; TRANSCRIPTION FACTORS; UBIQUITIN;

EID: 84867171020     PISSN: 00310808     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Richman EL, Kenfield SA, Stampfer MJ, Paciorek A, Carroll PR, Chan JM. Physical activity after diagnosis and risk of prostate cancer progression: data from the cancer of the prostate strategic urologic research endeavor. Cancer Res 2011; 71: 3889-95.
2. Liu J, Uygur B, Zhang Z, Shao L, Romero D, Vary C et al. Slug inhibits proliferation of human prostate cancer cells via downregulation of cyclin Dl expression. Prostate 2010; 70: 1768-77.
3. Sherr CJ, Roberts JM: CDK inhibitors: positive and negative regulators of Gl-phase progression. Genes Dev 1999;13:1501-12. (Pubitemid 29297917)
4. Bartkova J, Lukas J, Strauss M, Bartek J. Cyclin Dl oncoprotein aberrantly accumulates in malignancies of diverse histogenesis. Oncogene 1995; 10: 775-8.
5. Newman RM, Mobascher A, Mangold U, Koike C, Diah S, Schmidt M et al. Antizyme targets cyclin Dl for degradation. A novel mechanism for cell growth repression. J Biol Chem 2004;279:41504-11. (Pubitemid 39313591)
6. Newman RM, Mobascher A, Mangold U, Koike C, Diah S, Schmidt M et al. Antizyme targets cyclin D1 for degradation. A novel mechanism for cell growth repression. J Biol Chem 2004;279:41504-11. (Pubitemid 39313591)
7. Gupta PB, Kuperwasser C, Brunet JP, Ramaswamy S, Kuo WL, Gray JW et al. The melanocyte differentiation program predisposes to metastasis after neoplastic transformation. Nat Gene 2005;37:1047-54. (Pubitemid 41486656)
8. Sarbassov DD, Guertin DA, Ali SM, Sabatini DM: Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 2005;307:1098-101. (Pubitemid 40262113)
9. Hugo H, Ackland ML, Blick T, Lawrence MG, Clements JA, Williams ED et al. Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. J Cell Physiol 2007;213:374-83. (Pubitemid 47509716)
10. Moody SE, Perez D, Pan TC, Sarkisian CJ, Portocarrero CP, Sterner CJ et al. The transcriptional repressor Snail promotes mammary tumor recurrence. Cancer Cell 2005;8:197-209. (Pubitemid 41317591)
11. Giannelli G, Bergamini C, Fransvea E, Sgarra C, Antonaci S: Laminin-5 with transforming growth factor-betal induces epithelial to mesenchymal transition in hepatocellular carcinoma. Gastroenterology 2005; 129:1375-83. (Pubitemid 41597379)